Heart failure with preserved ejection fraction ... due to higher EFs and more preserved LV global longitudinal strain compared with men, the consensus decision pathway notes. ...

A low ejection fraction lets a doctor know that the active pumping phase of the heart isn't working. It's usually tied to some, but not all, types of heart failure.

Ancora Heart has reached the first enrollment milestone in the CORCINCH-HF pivotal trial of the AccuCinch® System in patients with heart failure.

For perspective, previous global clinical trial programs of agents such as SGLT2 inhibitors, sacubitril–valsartan, and spironolactone for heart failure with preserved ejection fraction showed ...

Heart failure with reduced ejection fraction (HFrEF) represents a significant global health burden, affecting over 64 million individuals and resulting in substantial morbidity and mortality, ...

Preventing onset and development of heart failure with preserved ejection fraction. Story by Ana María Rodríguez • 2w. A n international team of researchers at the University of Manchester, ...

Solomon SD, McMurray JJV, Vaduganathan M, et al. Finerenone in heart failure with mildly reduced or preserved ejection fraction. New England Journal of Medicine . Published online September 1 ...

The FINEARTS-HF Trial. In FINEARTS-HF, 6016 patients with heart failure and a left ventricular ejection fraction of at least 40% (mean, 54%) were randomized to finerenone (at a maximum dose of 20 ...

An international team of researchers has discovered a natural mechanism that protects the heart from heart failure with preserved ejection fraction (HFpEF), a serious condition in need of ...